GleamWall
中文EN

FOXO FOXO TECHNOLOGIES INC.

Services-Commercial Physical & Biological Research · OTC · SEC CIK 1812360 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY44.5%
TTM net income YoY73.2%
TTM EPS YoY—
Revenue 3-yr CAGR261.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin7.4%
Net margin-12.3%
FCF margin-0.1%
EBITDA margin10.5%

Returns

ROE-25.9%
ROA-5.5%
ROIC (approx.)12.6%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets100.0%
Debt / equity0.00x
Current ratio0.10x
Interest coverage0.37x

Cash quality & payout

Operating cash flow / net income-0.00x
Accruals ratio-5.5%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$7.00M$4.72M$5.17M$4.43M$3.55M$5.22M$3.17M$2.82M
R&D expense$0$23,700$35,550$35,219$77,096$40,183$30,000$267
SG&A expense$3.00M$2.68M$2.88M$3.50M$2.47M$2.62M$2.76M$3.03M
Operating income$1.58M$8.75M-$276,851-$8.49M-$859,821$567,121-$1.55M-$3.99M
Interest expense$1.35M$1.31M$973,135$601,239$934,223$1.01M$889,792$2.11M
Pretax income$96,281$8.14M-$1.46M-$9.60M-$1.88M-$526,306-$620,808-$6.80M
Net income$101,301$8.14M-$1.45M-$9.42M-$1.88M-$522,021-$616,458-$6.79M
EBITDA$1.75M$8.92M-$105,757-$8.33M-$716,618$569,378-$1.40M-$3.55M
EPS (diluted)————————
Balance sheet
Cash & equivalents$42,678$58,409$65,896$207,453$628,557$321,789$16,907$68,268
Receivables$3.47M$4.14M$3.91M$2.47M$3.16M$4.92M$2.65M$2.27M
Inventory$161,033$160,469$188,565$183,627$7,747——$161,466
Current assets$4.05M$4.76M$4.49M$3.11M$4.17M$5.63M$3.19M$2.88M
PP&E, net$265,019$286,865$303,544$322,357$326,624$307,202$328,030$364,481
Goodwill$26.53M$27.79M$27.79M$27.82M$34.83M$31.30M$30.60M$25.46M
Intangibles$9.61M$9.76M$9.78M$9.77M$9.10M$9.01M$9.01M$9.02M
Total assets$43.60M$45.89M$45.79M$44.58M$52.09M$50.02M$47.01M$41.71M
Current liabilities$39.82M$40.62M$31.56M$28.66M$28.64M$32.90M$33.79M$31.20M
Total liabilities$43.60M$44.98M$36.15M$33.50M$31.96M$36.34M$37.36M$36.44M
Shareholders' equity$86,337$988,306$9.71M$11.14M$20.20M$13.74M$9.71M$5.32M
Cash flow statement
Operating cash flow$395,042$298,674-$577,898-$104,030-$44,784-$2.38M-$1.34M-$1.85M
Capital expenditure$0$5,379$3,995$18,741$28,380———
Free cash flow$395,042$293,295-$581,893-$122,771-$73,164———
Investing cash flow$0-$5,379-$3,995-$18,741-$621,965——-$671
Financing cash flow-$410,773-$300,782$440,336-$298,333$973,517$2.70M$1.29M$1.88M
Depreciation & amortization$169,162$175,793$171,094$164,412$143,203$2,257$143,044$438,585
Stock-based compensation$0-$9.10M—$1-$210,804$18,878$27,716-$194,565

Free plan shows the latest 8 periods; Pro shows all 24 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.